Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, July 16, 2019
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
[ Tue, Jul 16th 2019
] - WOPRAI
Mon, July 15, 2019
[ Mon, Jul 15th 2019
] - WOPRAI
[ Mon, Jul 15th 2019
] - WOPRAI
[ Mon, Jul 15th 2019
] - WOPRAI
[ Mon, Jul 15th 2019
] - WOPRAI
[ Mon, Jul 15th 2019
] - WOPRAI
[ Mon, Jul 15th 2019
] - WOPRAI
[ Mon, Jul 15th 2019
] - WOPRAI
Matthew Harrison Maintained (AMGN) at Buy with Decreased Target to $207 on, Jul 15th, 2019
Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Buy with Decreased Target from $211 to $207 on, Jul 15th, 2019.
Matthew has made no other calls on AMGN in the last 4 months.
There is 1 other peer that has a rating on AMGN. Out of the 1 peers that are also analyzing AMGN, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Ian Somaiya of "BMO Capital" Initiated at Buy and Held Target at $228 on, Friday, March 15th, 2019
